Search Results 221-230 of 13740 for monoclonal antibody
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer ...
Binding of circulating PCSK9 by parenteral monoclonal antibodies results in augmented recirculation of the LDL receptor to the hepatocyte surface and ...
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...
Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image · Mayo Clinic Q&A podcast: Regenerative medicine helps with facial ...
... monoclonal antibody. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.